You are here
US to Test Ebola Vaccine in Humans Amid Growing Outbreak in West Africa
Primary tabs
An undated photo from National Institute of Allergy and Infectious Diseases and GlaxoSmithKline shows a vaccine candidate that will be used in the upcoming human trials. NIAID/GSK/AP Photo
abcnews.go.com - by Katie Moisse - August 28, 2014
U.S. scientists will begin testing an Ebola vaccine in humans next week, health officials announced today. But it could take 11 months to learn whether the vaccine is safe as the virus’ toll in West Africa continues to rise. . .
. . . The experimental vaccine, co-developed by the National Institutes of Health and GlaxoSmithKline, “performed extremely well in protecting nonhuman primates from Ebola infection,” Dr. Anthony Fauci, director of the NIH’s infectious disease branch, said.
Now it will be tested in 20 healthy adults to make sure it’s safe and effective in mounting an immune response.
Recent Comments